Concepedia

Gregory J. Finn

GJ

Statistics

Publications

8

Citations

603

H-Index

8

Active since

2002

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Loughborough University

Tallaght University Hospital

National University of Ireland, Maynooth

Gregory J. Finn is an author at Beth Israel Deaconess Medical Center specializing in medicine, cell biology, and pharmacology.

Top concepts

Publications per year

2002–2005

8

Publications

8

In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines

Gregory J. Finn, Emma Kenealy, Bernadette S. Creaven et al. · Cancer Letters · 2002 · 133 citations

, , +2

Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase

Gregory J. Finn, Bernadette S. Creaven, Denise A. Egan · Biochemical Pharmacology · 2004 · 91 citations

, , +7

Synthesis, X-ray crystal structure, anti-fungal and anti-cancer activity of [Ag2(NH3)2(salH)2] (salH2=salicylic acid)

Barry Coyle, Malachy McCann, Kevin Kavanagh et al. · Journal of Inorganic Biochemistry · 2004 · 87 citations

, , +3

Synthesis, antimicrobial activity and chemotherapeutic potential of inorganic derivatives of 2-(4′-thiazolyl)benzimidazole{thiabendazole}: X-ray crystal structures of [Cu(TBZH)2Cl]Cl·H2O·EtOH and TBZH2NO3 (TBZH=thiabendazole)

Michael Devereux, Malachy McCann, Denis O Shea et al. · Journal of Inorganic Biochemistry · 2004 · 85 citations

, , +8

Modulation of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin mediates apoptosis in renal carcinoma cells

Gregory J. Finn, Bernadette S. Creaven, Denise A. Egan · European Journal of Pharmacology · 2003 · 59 citations

, , +11

1–5 of 8